AFX Stock Overview
Operates as a medical technology company in Germany, rest of Europe, North America, and Asia. More details
| Snowflake Score | |
|---|---|
| Valuation | 3/6 |
| Future Growth | 3/6 |
| Past Performance | 1/6 |
| Financial Health | 5/6 |
| Dividends | 3/6 |
Community vs My Fair Value
Select a narrative for quick price alerts from the community, or create your own.
VISUMAX 800 Approval In China Will Strengthen Future Market Position
Carl Zeiss Meditec AG Competitors
Price History & Performance
| Historical stock prices | |
|---|---|
| Current Share Price | €58.85 |
| 52 Week High | €101.50 |
| 52 Week Low | €44.28 |
| Beta | 1.23 |
| 1 Month Change | -10.43% |
| 3 Month Change | 3.16% |
| 1 Year Change | -41.56% |
| 3 Year Change | -50.34% |
| 5 Year Change | -32.86% |
| Change since IPO | 68.14% |
Recent News & Updates
Are Investors Undervaluing Carl Zeiss Meditec AG (ETR:AFX) By 39%?
Apr 28
Carl Zeiss Meditec (ETR:AFX) Will Pay A Smaller Dividend Than Last Year
Mar 23Recent updates
Are Investors Undervaluing Carl Zeiss Meditec AG (ETR:AFX) By 39%?
Apr 28Carl Zeiss Meditec (ETR:AFX) Will Pay A Smaller Dividend Than Last Year
Mar 23Shareholders Will Probably Be Cautious Of Increasing Carl Zeiss Meditec AG's (ETR:AFX) CEO Compensation At The Moment
Mar 20After Leaping 25% Carl Zeiss Meditec AG (ETR:AFX) Shares Are Not Flying Under The Radar
Mar 15These 4 Measures Indicate That Carl Zeiss Meditec (ETR:AFX) Is Using Debt Extensively
Mar 03Carl Zeiss Meditec (ETR:AFX) Might Be Having Difficulty Using Its Capital Effectively
Feb 10More Unpleasant Surprises Could Be In Store For Carl Zeiss Meditec AG's (ETR:AFX) Shares After Tumbling 26%
Jan 10Is Carl Zeiss Meditec AG (ETR:AFX) Potentially Undervalued?
Dec 28
AI-Powered Innovations Like KINEVO 900 S And VISUMAX 800 Set To Drive Revenue Growth
Dec 22 New product pipeline and integration of DORC expected to drive revenue and enhance net margins with innovative AI medical solutions.Calculating The Fair Value Of Carl Zeiss Meditec AG (ETR:AFX)
Dec 04Carl Zeiss Meditec AG's (ETR:AFX) Share Price Could Signal Some Risk
Nov 19Some Investors May Be Worried About Carl Zeiss Meditec's (ETR:AFX) Returns On Capital
Sep 19Does Carl Zeiss Meditec (ETR:AFX) Have A Healthy Balance Sheet?
Sep 06Are Investors Undervaluing Carl Zeiss Meditec AG (ETR:AFX) By 27%?
Aug 23At €62.50, Is It Time To Put Carl Zeiss Meditec AG (ETR:AFX) On Your Watch List?
Aug 09Carl Zeiss Meditec AG's (ETR:AFX) 25% Dip Still Leaving Some Shareholders Feeling Restless Over Its P/ERatio
Jul 11Returns On Capital At Carl Zeiss Meditec (ETR:AFX) Have Stalled
Jun 10Carl Zeiss Meditec AG's (ETR:AFX) Popularity With Investors Is Under Threat From Overpricing
May 26Carl Zeiss Meditec AG Just Beat Earnings Expectations: Here's What Analysts Think Will Happen Next
May 11Calculating The Fair Value Of Carl Zeiss Meditec AG (ETR:AFX)
May 09Shareholder Returns
| AFX | DE Medical Equipment | DE Market | |
|---|---|---|---|
| 7D | 4.0% | 4.9% | 4.3% |
| 1Y | -41.6% | -13.7% | 11.0% |
Return vs Industry: AFX underperformed the German Medical Equipment industry which returned -13.8% over the past year.
Return vs Market: AFX underperformed the German Market which returned 10.9% over the past year.
Price Volatility
| AFX volatility | |
|---|---|
| AFX Average Weekly Movement | 8.7% |
| Medical Equipment Industry Average Movement | 5.6% |
| Market Average Movement | 6.3% |
| 10% most volatile stocks in DE Market | 12.9% |
| 10% least volatile stocks in DE Market | 3.1% |
Stable Share Price: AFX has not had significant price volatility in the past 3 months compared to the German market.
Volatility Over Time: AFX's weekly volatility (9%) has been stable over the past year.
About the Company
| Founded | Employees | CEO | Website |
|---|---|---|---|
| 1846 | 5,730 | Markus Weber | www.zeiss.com/meditec-ag/de/investor-relations.html?vaURL=www.zeiss.de/meditec-ag/ir |
Carl Zeiss Meditec AG operates as a medical technology company in Germany, rest of Europe, North America, and Asia. It operates in two segments, Ophthalmology and Microsurgery. The Ophthalmology segment offers products and solutions for the diagnosis and treatment of chronic eye diseases, such as ametropia (refraction), cataracts, glaucoma, and renital disorders.
Carl Zeiss Meditec AG Fundamentals Summary
| AFX fundamental statistics | |
|---|---|
| Market cap | €5.15b |
| Earnings (TTM) | €157.03m |
| Revenue (TTM) | €2.08b |
32.8x
P/E Ratio2.5x
P/S RatioIs AFX overvalued?
See Fair Value and valuation analysisEarnings & Revenue
| AFX income statement (TTM) | |
|---|---|
| Revenue | €2.08b |
| Cost of Revenue | €993.40m |
| Gross Profit | €1.09b |
| Other Expenses | €931.20m |
| Earnings | €157.03m |
Last Reported Earnings
Dec 31, 2024
Next Earnings Date
May 13, 2025
| Earnings per share (EPS) | 1.79 |
| Gross Margin | 52.28% |
| Net Profit Margin | 7.54% |
| Debt/Equity Ratio | 26.9% |
How did AFX perform over the long term?
See historical performance and comparisonDividends
1.0%
Current Dividend Yield34%
Payout RatioCompany Analysis and Financial Data Status
| Data | Last Updated (UTC time) |
|---|---|
| Company Analysis | 2025/04/28 03:43 |
| End of Day Share Price | 2025/04/25 00:00 |
| Earnings | 2024/12/31 |
| Annual Earnings | 2024/09/30 |
Data Sources
The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.
| Package | Data | Timeframe | Example US Source * |
|---|---|---|---|
| Company Financials | 10 years |
| |
| Analyst Consensus Estimates | +3 years |
|
|
| Market Prices | 30 years |
| |
| Ownership | 10 years |
| |
| Management | 10 years |
| |
| Key Developments | 10 years |
|
* Example for US securities, for non-US equivalent regulatory forms and sources are used.
Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more.
Analysis Model and Snowflake
Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.
Learn about the world class team who designed and built the Simply Wall St analysis model.
Industry and Sector Metrics
Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on Github.
Analyst Sources
Carl Zeiss Meditec AG is covered by 32 analysts. 16 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.
| Analyst | Institution |
|---|---|
| Samuel England | Berenberg |
| Scott Bardo | Berenberg |
| Julien Ouaddour | BofA Global Research |